These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1845118)

  • 1. Anti-HIV-1 ADCC: clinical and therapeutic implications.
    Weinhold KJ
    Biotechnol Ther; 1991; 2(1-2):147-57. PubMed ID: 1845118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS; Stanley SD; Nastala CA; Austin AA; Bartlett JA; Stine KC; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1990 May; 144(9):3375-84. PubMed ID: 2329275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
    Weinhold KJ; Tyler DS; Lyerly HK
    Dev Biol Stand; 1990; 72():343-8. PubMed ID: 2282991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
    Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
    J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.
    Gupta N; Arthos J; Khazanie P; Steenbeke TD; Censoplano NM; Chung EA; Cruz CC; Chaikin MA; Daucher M; Kottilil S; Mavilio D; Schuck P; Sun PD; Rabin RL; Radaev S; Van Ryk D; Cicala C; Fauci AS
    Virology; 2005 Feb; 332(2):491-7. PubMed ID: 15680414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated cytotoxicity can protect PBMC from infection by cell-associated HIV-1.
    Hildreth JE; Hampton R; Halsey NA
    Clin Immunol; 1999 Feb; 90(2):203-12. PubMed ID: 10080832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.
    Ljunggren K; Karlson A; Fenyö EM; Jondal M
    Clin Exp Immunol; 1989 Feb; 75(2):184-9. PubMed ID: 2649286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs.
    Tyler DS; Stanley SD; Bartlett JA; Bolognesi DP; Weinhold KJ
    J Surg Res; 1998 Oct; 79(2):115-20. PubMed ID: 9758725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
    Jewett A; Giorgi JV; Bonavida B
    J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
    Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
    J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):27-49. PubMed ID: 18388299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC).
    Cox JH
    Methods Mol Med; 1999; 17():373-81. PubMed ID: 21380688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells in HIV-1 infection: role of NK cell-mediated non-cytolytic mechanisms in pathogenesis of HIV-1 infection.
    Kottilil S
    Indian J Exp Biol; 2003 Nov; 41(11):1219-25. PubMed ID: 15332487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.